Stay updated on XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.

Latest updates to the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe study record history now shows an added Revision: v3.5.2 and a deleted Revision: v3.5.0.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry v3.5.0 was added to the Record History, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check42 days agoChange DetectedThe history now shows a new revision entry v3.4.3. The previous revision v3.4.2 has been removed.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.2 was added; the notice about government funding lapses and the older Revision: v3.4.1 were removed from the history.SummaryDifference0.9%

- Check78 days agoChange DetectedA site-wide notice about a lapse in government funding and operating status was added. The record history now shows a new version entry, Revision: v3.4.1, and the previous entry v3.4.0 was removed.SummaryDifference0.9%

- Check85 days agoChange DetectedThe history view now shows a glossary toggle, highlights additions in green and deletions in red, and displays revision notes such as Revision: v3.4.0, with No FEAR Act data reference removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.